Sex differences in the pharmacokinetics of pioglitazone in rats (Q44604963)

4 December 2017

title

Sex differences in the pharmacokinetics of pioglitazone in rats (English)

1 reference

4 December 2017

1 reference

https://api.crossref.org/works/10.1016/S1532-0456(03)00194-7

17 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1532-0456(03)00194-7

17 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1532-0456(03)00194-7

17 March 2024

1 reference

Yukiyoshi Fujita

1

1 reference

4 December 2017

Yasuhiko Yamada

2

1 reference

4 December 2017

Makiko Kusama

3

1 reference

4 December 2017

Toshimasa Yamauchi

4

1 reference

4 December 2017

Junji Kamon

5

1 reference

4 December 2017

Takashi Kadowaki

6

1 reference

4 December 2017

Tatsuji Iga

7

1 reference

4 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14522601

17 March 2024

publication date

1 September 2003

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S1532045603001947?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1532-0456(03)00194-7

https://api.elsevier.com/content/article/PII:S1532045603001947?httpAccept=text/plain

17 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1532-0456(03)00194-7

Comparative Biochemistry and Physiology C: Toxicology and Pharmacology

17 March 2024

published in

1 reference

4 December 2017

volume

136

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

85-94

1 reference

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Efficacy of troglitazone on body fat distribution in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

The effects of androgens and estrogens on preadipocyte proliferation in human adipose tissue: influence of gender and site

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids.

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

The effect of pioglitazone on glucose metabolism and insulin uptake in the perfused liver and hindquarter of high-fructose-fed rats

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Effect of troglitazone on body fat distribution in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Sex-dependent metabolism of xenobiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Pioglitazone time-dependently reduces tumour necrosis factor-alpha level in muscle and improves metabolic abnormalities in Wistar fatty rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Studies on antidiabetic agents. XII. Synthesis and activity of the metabolites of (+/-)-5(-)[p(-)[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]-2,4- thiazolidinedione (pioglitazone)

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Adipogenesis and obesity: rounding out the big picture

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Statistical moments in pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

High-performance liquid chromatographic determination of pioglitazone and its metabolites in human serum and urine

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1532-0456%2803%2900194-7

7 January 2021

Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans

5

1 reference

https://api.crossref.org/works/10.1016/S1532-0456(03)00194-7

Sex-dependent pharmacokinetics of S(-)-hydroxyhexamide, a pharmacologically active metabolite of acetohexamide, in rats

17 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/S1532-0456(03)00194-7

Studies on the metabolism of the new antidiabetic agent pioglitazone. Identification of metabolites in rats and dogs

17 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/S1532-0456(03)00194-7

Disposition and metabolism of the hypoglycemic agent pioglitazone in rats

17 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/S1532-0456(03)00194-7

Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys

17 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/S1532-0456(03)00194-7

17 March 2024

Identifiers

1 reference

4 December 2017

1 reference